Management of Bowel Incontinence
Begin with conservative measures including dietary modification to eliminate poorly absorbed sugars and caffeine, loperamide 2 mg taken 30 minutes before breakfast (titrated up to 16 mg daily), fiber supplementation to optimize stool consistency, and scheduled toileting every 2 hours while awake—progressing to biofeedback therapy if these fail, before considering any surgical interventions. 1
Initial Assessment and Risk Factor Identification
Characterize the incontinence pattern meticulously to guide treatment:
- Document whether episodes are urge-related (warning before leakage), passive (no warning), or combined, as this determines therapeutic approach 1, 2
- Identify relationship to meals, activity level, and timing to leverage the gastrocolic reflex in scheduled toileting 1
- Evaluate for diarrhea as the primary driver, since bowel disturbances and rectal urgency are the most significant independent risk factors for fecal incontinence 1, 2
- Review all medications, particularly opioids and anticholinergics, which worsen bowel dysfunction 1
- Assess mobility status, as needing assistance getting to the toilet is a strong independent predictor of incontinence 1
First-Line Conservative Management
Dietary and bowel habit modification:
- Obtain a careful dietary history to identify poorly absorbed sugars (lactose, fructose, sorbitol) and excessive caffeine intake, then implement elimination trials 1
- Add fiber supplementation to improve stool consistency and reduce diarrhea-associated incontinence 1
Pharmacologic management for diarrhea-associated incontinence:
- Start loperamide 2 mg taken 30 minutes before breakfast, titrating up to 16 mg daily as needed 1, 3
- Loperamide works by slowing intestinal motility, increasing anal sphincter tone, reducing urgency, and prolonging intestinal transit time 3
Scheduled toileting program:
- Implement toilet sits every 2 hours while awake and every 4 hours at night to establish a predictable bowel routine 1
- Schedule sits 15-30 minutes after meals to capitalize on the gastrocolic reflex 1
Second-Line: Biofeedback Therapy
If basic conservative measures fail after adequate trial, biofeedback is the next step rather than proceeding directly to invasive interventions 4, 1:
- Biofeedback uses electronic and mechanical devices to improve pelvic floor strength, rectal sensation, and rectal tolerance 1
- This approach improves symptoms in more than 70% of patients with defecatory disorders and is particularly attractive because it is safe, well-tolerated, and free of morbidity 4, 1, 5
- Success depends on patient motivation, therapist expertise, frequency and intensity of retraining, and involvement of behavioral psychologists and dietitians as needed 4
Diagnostic Testing (When Conservative Measures Fail)
Perform targeted testing only after conservative therapy and biofeedback have been attempted 1:
- Anorectal manometry identifies anal sphincter weakness, altered rectal sensation, and impaired rectal balloon expulsion 1
- Endoanal ultrasound or MRI visualizes internal and external sphincter defects when considering surgical interventions or devices 1
Minimally Invasive Interventions
For patients failing conservative therapy and biofeedback 1:
- Dextranomer microspheres in non-animal stabilized hyaluronic acid (NASHA Dx) is FDA-approved, with 52% of patients achieving ≥50% improvement in incontinence episodes at 6 months 1
- Sacral nerve stimulation should be considered for medically-refractory severe fecal incontinence after failure of conservative therapy, biofeedback, and perianal bulking 1
Surgical Options (Last Resort)
Reserve surgery for severe cases unresponsive to all conservative and minimally invasive measures 1:
- Sphincteroplasty may be considered for women with recent sphincter injuries or those presenting later with symptoms unresponsive to conservative and biofeedback therapy 1
- Surgical correction of major anatomic defects (rectovaginal fistula, full-thickness rectal prolapse, fistula in ano) is necessary when present 1
- Colostomy should be considered in patients with severe fecal incontinence who have failed all other treatments and are not candidates for or have failed barrier devices, minimally invasive interventions, and sphincteroplasty 1
Critical Clinical Pitfalls to Avoid
Many patients labeled "refractory" have not received optimal conservative therapy 1:
- Ensure meticulous characterization of bowel habits, complete dietary elimination trials, and appropriate titration of antidiarrheal medications before escalating to invasive interventions 1
- Do not discontinue treatment prematurely—bowel management programs often require months to restore normal motility and rectal sensation 1
- Recognize that fecal incontinence has a devastating impact on quality of life, causing loss of confidence, self-respect, and social isolation, yet many patients do not volunteer this symptom due to embarrassment 1, 2, 6
- A 50% reduction in incontinence episodes is considered clinically significant improvement in clinical trials, so set realistic expectations with patients 1